87 related articles for article (PubMed ID: 1843183)
21. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schriger A
J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
[TBL] [Abstract][Full Text] [Related]
22. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the tolerance and effectiveness of Diltiazem LP 300 mg in hypertensive patients with chronic renal insufficiency].
Bernadet-Monrozies P; Poilleux E; Suc JM
Ann Cardiol Angeiol (Paris); 1998 Oct; 47(8):589-94. PubMed ID: 9809145
[TBL] [Abstract][Full Text] [Related]
24. [Arterial hypertension in patients on chronic hemodialysis].
Zogović J; Mladenović Lj
Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
[TBL] [Abstract][Full Text] [Related]
25. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
[TBL] [Abstract][Full Text] [Related]
26. Verapamil toxicity: an unusual case report and review of the literature.
Batalis NI; Harley RA; Schandl CA
Am J Forensic Med Pathol; 2007 Jun; 28(2):137-40. PubMed ID: 17525564
[TBL] [Abstract][Full Text] [Related]
27. [Verapamil-associated liver injury].
Odeh M; Oliven A
Harefuah; 1998 Jan; 134(1):36-7. PubMed ID: 9517278
[TBL] [Abstract][Full Text] [Related]
28. [The effects of slow-release verapamil in relation to plasma concentration in aged hypertensives. A study with continuous monitoring of arterial pressure and electrocardiogram].
Canonico V; Bonaduce D; De Caprio L; Nicolino A; Forgione L; Petretta M; Rengo F
G Ital Cardiol; 1990 Oct; 20(10):924-32. PubMed ID: 2090531
[TBL] [Abstract][Full Text] [Related]
29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
30. [Poisoning by delayed-release verapamil in renal insufficiency patients].
Daroca Pérez R; Alfaro Olea A; San Román Lazcano FJ; Jiménez Santolaya C
Med Clin (Barc); 1993 Oct; 101(14):557-8. PubMed ID: 8231404
[No Abstract] [Full Text] [Related]
31. Treatment of arterial hypertension with nifedipine in patients with chronic renal insufficiency.
Ambroso GC; Como G; Scalamogna A; Citterio A; Casati S; Ponticelli C
Clin Nephrol; 1985 Jan; 23(1):41-5. PubMed ID: 3978881
[TBL] [Abstract][Full Text] [Related]
32. The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment--a prospective ABPM study.
Covic A; Mititiuc I; Gusbeth-Tatomir P; Goldsmith DJ
J Nephrol; 2002; 15(5):497-506. PubMed ID: 12455715
[TBL] [Abstract][Full Text] [Related]
33. Calcium-channel blocking agents.
Leonard RG; Talbert RL
Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
[TBL] [Abstract][Full Text] [Related]
34. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
[TBL] [Abstract][Full Text] [Related]
35. Casual versus 24-hour ambulatory blood pressure recording in the evaluation of chronic administration of sustained-release verapamil.
Cardillo C; Savi L; Musumeci V; Mores N; Mettimano M; Costalunga A; Guerrera G; Melina D; Folli G
J Hum Hypertens; 1988 Mar; 1(4):281-5. PubMed ID: 3221375
[TBL] [Abstract][Full Text] [Related]
36. [Effects of sustained-release verapamil on hemodynamics and renal function of patients with moderate to severe chronic renal failure].
Schohn D; Maarek M; Jahn H
Presse Med; 1993 Nov; 22(37):1856-60. PubMed ID: 8115329
[TBL] [Abstract][Full Text] [Related]
37. Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency.
Ruilope LM; Casal MC; Guerrero L; Alcázar JM; Férnandez ML; Lahera V; Rodicio JL
Drugs; 1992; 44 Suppl 1():94-8. PubMed ID: 1283591
[TBL] [Abstract][Full Text] [Related]
38. Adverse interaction between clonidine and verapamil.
Jaffe R; Livshits T; Bursztyn M
Ann Pharmacother; 1994; 28(7-8):881-3. PubMed ID: 7949506
[TBL] [Abstract][Full Text] [Related]
39. Acute asthma associated with sustained-release verapamil.
Ben-Noun L
Ann Pharmacother; 1997 May; 31(5):593-5. PubMed ID: 9161656
[TBL] [Abstract][Full Text] [Related]
40. Toxic effects of diltiazem in a patient with chronic renal failure.
Patel R; Lipper B; Schwartzbard A; Nelson C; O'Connor MA; Frishman W
J Clin Pharmacol; 1994 Mar; 34(3):273-4. PubMed ID: 8021338
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
